Rare Immune-Regulatory Variants in Familial Multiple Sclerosis: Insights from Exome Sequencing and Molecular Modeling
Multiple sclerosis is a chronic autoimmune and neuroinflammatory disorder in which immune-mediated injury contributes to demyelination and neurodegeneration within the central nervous system. Although most cases arise through a complex interaction of many genetic and environmental factors, familial clustering provides an important opportunity to investigate rare inherited variants with stronger biological effects. The article by Torabi-Rahvar and colleagues examines this question in two Iranian multi-incident families with multiple affected relatives and evidence of genetic homogeneity. Such families are particularly informative because consanguinity and shared ancestry can increase the likelihood that recessive variants become homozygous in affected individuals. By focusing on familial multiple sclerosis rather than sporadic disease, the authors sought to identify genetic alterations that may be difficult to detect in conventional population-wide association studies.
Whole-Exome Sequencing Strategy and Variant Prioritization
The study used whole-exome sequencing to examine coding and exon-associated regions of the genome in selected affected and unaffected family members. The investigators first searched for single-nucleotide variants and small insertions or deletions that followed an autosomal recessive inheritance pattern, meaning that affected individuals would be expected to carry homozygous variants while unaffected parents would be heterozygous carriers. When single-nucleotide analysis did not fully explain the disease pattern, the authors expanded their analysis to copy-number variants, which are larger genomic deletions or duplications that can alter gene dosage, disrupt coding sequences, or generate fusion proteins. This broader strategy is scientifically important because structural variation is often underrepresented in genetic studies of complex immune-mediated diseases, despite its potential to reshape immune pathways.
Discovery of BTNL3 and BTNL8 Deletions in Family 1
In the first family, the most compelling findings were two co-segregating deletions involving the BTNL3 and BTNL8 genes. These deletions were homozygous in affected siblings and heterozygous in their unaffected parents, supporting an autosomal recessive inheritance model within that branch of the pedigree. The authors validated the deletions using conventional PCR and supported the segregation pattern with whole-exome read-depth and nearby SNP haplotype analysis. The affected cousin in the same extended family did not carry these deletions, indicating genetic heterogeneity, a common feature of complex diseases such as multiple sclerosis. This observation is important because it suggests that even within a single extended pedigree, more than one genetic route may contribute to similar clinical outcomes.
Immunological Significance of BTNL3 and BTNL8
BTNL3 and BTNL8 belong to the butyrophilin-like family of immune regulatory molecules and are closely related to pathways that influence T-cell activity. These proteins are especially relevant at epithelial barrier sites such as the gastrointestinal tract, where they contribute to immune surveillance and local immune tolerance. A central feature of the article is the interaction between BTNL3/BTNL8 and Vγ4-positive γδ T cells, a specialized T-cell population involved in tissue surveillance, cytokine production, and inflammatory responses. Under physiological conditions, BTNL3 and BTNL8 appear to help regulate γδ T-cell responsiveness, limiting excessive inflammatory signaling. Disruption of this regulatory axis may therefore create a permissive environment for immune dysregulation, which is highly relevant to multiple sclerosis pathogenesis.
Molecular Modeling of the BTNL8*3 Fusion Protein
A major strength of the study is its integration of genomic analysis with structural biology. The deletions identified in BTNL3 and BTNL8 are consistent with the formation of a BTNL8*3 fusion protein, combining portions of BTNL8 and BTNL3. Using AlphaFold3, SWISS-MODEL, HADDOCK2.4, and PRODIGY-based binding predictions, the authors compared the interaction of the normal BTNL8-BTNL3 heterodimer with the Vγ4 T-cell receptor against that of the BTNL8*3 fusion protein. The modeled BTNL8*3 interaction showed weaker binding than the native heterodimer, suggesting impaired engagement with the Vγ4 T-cell receptor. Biologically, this could reduce inhibitory signaling, weaken T-cell downregulation, and promote excessive production of inflammatory mediators such as IL-17 and IFN-γ, both of which are implicated in neuroinflammation.
The MBL2 Variant in Family 2 and the Complexity of Genetic Interpretation
In the second family, the authors identified a rare homozygous missense variant in MBL2, p.Pro101Leu, in one affected individual. MBL2 encodes mannose-binding lectin, an innate immune molecule involved in pathogen recognition and activation of the lectin complement pathway. Because complement activity and innate immune regulation may influence autoimmune susceptibility, MBL2 is biologically plausible as a modifier of disease risk. However, the variant did not fully co-segregate with multiple sclerosis across the extended family, because another affected individual carried the reference genotype. For this reason, the article appropriately interprets the MBL2 variant cautiously, suggesting that it is unlikely to be a primary causative mutation but may contribute as a genetic modifier in a broader multifactorial disease context.
Implications, Limitations, and Future Directions
This study highlights the value of family-based sequencing for uncovering rare and structural variants that may contribute to multiple sclerosis susceptibility. The BTNL3 and BTNL8 findings are particularly noteworthy because they connect inherited copy-number variation with γδ T-cell regulation, epithelial immune signaling, and potential neuroinflammatory mechanisms. Nevertheless, the conclusions remain preliminary because the proposed effects of the BTNL8*3 fusion protein and the MBL2 variant are based primarily on genetic segregation and computational modeling rather than direct functional assays. Future work should include cytokine profiling, T-cell activation studies, transcript-level validation, whole-genome sequencing, and replication in larger and ethnically diverse cohorts. Overall, the article provides a valuable framework for understanding how rare inherited immune-regulatory variants may contribute to familial multiple sclerosis and encourages deeper investigation of γδ T-cell biology in autoimmune neuroinflammation.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Torabi-Rahvar, M., Talebi, S., Salehi, N. et al. Exome Sequencing and Molecular Modeling Reveal Novel Loci in Familial Multiple Sclerosis: The Importance of BTNL3 and BTNL8 in Disease Pathogenesis. Mol Neurobiol 63, 227 (2026). https://doi.org/10.1007/s12035-025-05436-w
